These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 16409196

  • 1. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood.
    Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP.
    Allergy; 2006 Feb; 61(2):198-201. PubMed ID: 16409196
    [Abstract] [Full Text] [Related]

  • 2. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G, Hurley C, Turcanu V, Lack G.
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [Abstract] [Full Text] [Related]

  • 3. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children.
    Rolinck-Werninghaus C, Hamelmann E, Keil T, Kulig M, Koetz K, Gerstner B, Kuehr J, Zielen S, Schauer U, Kamin W, Von Berg A, Hammermann J, Weinkauf B, Weidinger G, Stenglein S, Wahn U, Omalizumab Rhinitis Study Group.
    Allergy; 2004 Sep; 59(9):973-9. PubMed ID: 15291906
    [Abstract] [Full Text] [Related]

  • 4. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy of preseasonal grass pollen immunotherapy in children.
    Eng PA, Reinhold M, Gnehm HP.
    Allergy; 2002 Apr; 57(4):306-12. PubMed ID: 11906360
    [Abstract] [Full Text] [Related]

  • 6. [Preventive immunotherapy].
    Boquete M, Carballada F, Expósito F, González A.
    Allergol Immunopathol (Madr); 2000 Apr; 28(3):89-93. PubMed ID: 10867376
    [Abstract] [Full Text] [Related]

  • 7. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
    Dahl R, Stender A, Rak S.
    Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
    [Abstract] [Full Text] [Related]

  • 8. Long-term clinical efficacy of grass-pollen immunotherapy.
    Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT.
    N Engl J Med; 1999 Aug 12; 341(7):468-75. PubMed ID: 10441602
    [Abstract] [Full Text] [Related]

  • 9. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N, Li Gotti F, Mangano G, Paolino G, Mastruzzo C, Vancheri C, Lisitano N, Polosa R.
    Ann Ital Med Int; 2004 Aug 12; 19(2):98-108. PubMed ID: 15317270
    [Abstract] [Full Text] [Related]

  • 10. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV, Hamelmann E, Zielen S, Kamin W, Bergmann KC, Sieder C, Stenglein S, Seyfried S, Wahn U, DUAL study group.
    Clin Exp Allergy; 2009 Feb 12; 39(2):271-9. PubMed ID: 19016798
    [Abstract] [Full Text] [Related]

  • 11. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy.
    Kopp MV, Hamelmann E, Bendiks M, Zielen S, Kamin W, Bergmann KC, Klein C, Wahn U, DUAL study group.
    Pediatr Allergy Immunol; 2013 Aug 12; 24(5):427-33. PubMed ID: 23799935
    [Abstract] [Full Text] [Related]

  • 12. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
    Kopp MV, Stenglein S, Kamin W, Friedrichs F, von Berg A, Zielen S, Hamelmann E, Wahn U, Kuehr J.
    Pediatr Allergy Immunol; 2007 Sep 12; 18(6):523-7. PubMed ID: 17680911
    [Abstract] [Full Text] [Related]

  • 13. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
    Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR.
    J Allergy Clin Immunol; 2001 Jan 12; 107(1):87-93. PubMed ID: 11149996
    [Abstract] [Full Text] [Related]

  • 14. Does specific immunotherapy injection cause an increase in bronchial reactivity?
    Keskin O, Tuncer A, Yildirim S, Bursali B, Adalioglu G, Sekerel BE.
    J Asthma; 2005 Nov 12; 42(9):765-8. PubMed ID: 16316871
    [Abstract] [Full Text] [Related]

  • 15. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.
    Niggemann B, Jacobsen L, Dreborg S, Ferdousi HA, Halken S, Høst A, Koivikko A, Koller D, Norberg LA, Urbanek R, Valovirta E, Wahn U, Möller C, PAT Investigator Group.
    Allergy; 2006 Jul 12; 61(7):855-9. PubMed ID: 16792584
    [Abstract] [Full Text] [Related]

  • 16. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr 12; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 17. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
    Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B.
    Allergy; 2004 Dec 12; 59(12):1285-93. PubMed ID: 15507097
    [Abstract] [Full Text] [Related]

  • 18. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
    Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE, Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A.
    J Allergy Clin Immunol; 2004 Oct 12; 114(4):851-7. PubMed ID: 15480326
    [Abstract] [Full Text] [Related]

  • 19. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
    Williams A, Henzgen M, Rajakulasingam K.
    Eur Ann Allergy Clin Immunol; 2007 Apr 12; 39(4):123-6. PubMed ID: 17523386
    [Abstract] [Full Text] [Related]

  • 20. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
    Klimek L, Mewes T, Wolf H, Hansen I, Schnitker J, Mann WJ.
    Otolaryngol Head Neck Surg; 2005 Oct 12; 133(4):538-43. PubMed ID: 16213926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.